Relapse of microscopic polyangiitis after vaccination against COVID‐19: A case report
Edoardo Conticini, Miriana d’Alessandro, Laura Bergantini, Elena Bargagli, Francesco Gentili, Maria Antonietta Mazzei, Luca Cantarini, Bruno Frediani
Abstract
Approval of the first vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has dramatically changed the prospects of controlling coronavirus disease 2019 (COVID-19). According to the first available data, these vaccines appear effective and safe, but no clinical trials have included patients with rheumatic diseases, and no data exists on efficacy and safety in such subjects.
Topics & Concepts
MedicineTransplantationRespiratory MedicineLung transplantationIntensive care unitGeneral surgeryFamily medicineInternal medicineSurgeryVasculitis and related conditionsHeparin-Induced Thrombocytopenia and ThrombosisPeripheral Neuropathies and Disorders